According to the most recent statistics available, cancers of the urinary tract are an important public health issue, impacting some 386,000 people worldwide in 2008. 1 Urothelial bladder cancer is ...

AIxMed, a recognized innovator in AI diagnostics for urine cytology, and PathNet, a leading diagnostic laboratory, announced a strategic partnership. This collaboration aims to enhance PathNet's ...

Please provide your email address to receive an email when new articles are posted on . A urinary DNA methylation test outperformed the nuclear matrix protein 22 test or urine cytology test.

CorePlus announced the implementation of AIxURO, a state-of-the-art software solution that utilizes artificial intelligence to significantly improve the accuracy and efficiency of bladder cancer ...

A noninvasive urinary DNA methylation test demonstrated high sensitivity for detecting high-grade or invasive bladder cancer. A urinary DNA methylation test displayed superior sensitivity for ...

urine sample Half of urologists order routine urine cytology in patients with low-risk non-muscle-invasive bladder cancer. Routine urine cytology is not warranted in patients with low-risk ...

A streamlined urine DNA test more accurately detects primary bladder cancer, reducing the need for more invasive cystoscopy, reports The Journal of Molecular Diagnostics Lead investigator Sungwhan An, ...

The role of robot-assisted adrenalectomy for large pheochromocytoma pressing inferior vena cava or extending to retrovena cava space. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

A urinary DNA methylation test demonstrated high sensitivity and specificity for detecting high-grade or invasive bladder cancer, outperforming both nuclear matrix protein 22 (NMP22) and urine ...